CSS
HOWL icon

Cubist Systematic Strategies’s Werewolf Therapeutics HOWL Stock Holding History

Cubist Systematic Strategies’s Portfolio HOWL Stock Details HOWL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$92K Buy
+46,711
New +$64K ﹤0.01% 2785
2024
Q3 		– Sell
-28,371
Closed -$69.2K – 3205
2024
Q2 		$69.2K Sell
28,371
-12,278
-30% -$59K ﹤0.01% 2671
2024
Q1 		$263K Buy
+40,649
New +$237K ﹤0.01% 2938
2022
Q3 		– Sell
-13,250
Closed -$54K – 4550
2022
Q2 		$54K Buy
+13,250
New +$60.5K ﹤0.01% 4084

Other funds holding HOWL

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
DF
DC Funds Mclean, Virginia $1.49M AUM 18.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cubist Systematic Strategies's HOWL Position: Q3 2025 in Review

Cubist Systematic Strategies opened a new position in Werewolf Therapeutics (HOWL) in Q3 2025: 46,711 shares worth $92K. The stake represents ﹤0.01% of the portfolio and ranks #2785 among its holdings. This is a return to the name: Cubist Systematic Strategies previously reported a position in HOWL as recently as Q2 2024.

Cubist Systematic Strategies first reported a position in HOWL in Q2 2022 and has held it in 4 quarters since. The position peaked at $263K in Q1 2024. 62 funds tracked by Wall St. Rank hold HOWL as of Q3 2025.

  • Cubist Systematic Strategies held 46,711 shares of Werewolf Therapeutics worth $92K as of Q3 2025.
  • Werewolf Therapeutics was a new Cubist Systematic Strategies position in Q3 2025.
  • Werewolf Therapeutics made up ﹤0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #2785 holding.
  • Cubist Systematic Strategies first reported a position in Werewolf Therapeutics in Q2 2022 and has held it in 4 quarters since.
  • Cubist Systematic Strategies's Werewolf Therapeutics position peaked at $263K in Q1 2024.
  • 62 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.